Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2009 1
2010 1
2011 2
2012 2
2013 2
2014 5
2015 6
2016 4
2017 4
2018 5
2019 8
2020 19
2021 13
2022 14
2023 27
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials.
Iqbal J, Wu HX, Hu N, Zhou YH, Li L, Xiao F, Wang T, Jiang HL, Xu SN, Huang BL, Zhou HD. Iqbal J, et al. Obes Rev. 2022 Jun;23(6):e13435. doi: 10.1111/obr.13435. Epub 2022 Feb 22. Obes Rev. 2022. PMID: 35194917 Review.
Subgroup analysis showed greater treatment effect of semaglutide than liraglutide. Vomiting, nausea, dyspepsia, diarrhea, constipation, and abdominal pain were GLP-1 RA-associated common adverse effects....
Subgroup analysis showed greater treatment effect of semaglutide than liraglutide. Vomiting, nausea, dyspepsia, diarrhea, cons …
MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.
Madariaga A, Lau J, Ghoshal A, Dzierżanowski T, Larkin P, Sobocki J, Dickman A, Furness K, Fazelzad R, Crawford GB, Lheureux S. Madariaga A, et al. Support Care Cancer. 2022 Jun;30(6):4711-4728. doi: 10.1007/s00520-022-06889-8. Epub 2022 Mar 10. Support Care Cancer. 2022. PMID: 35274188 Free PMC article.
The review was restricted to studies published in English, but no restrictions were placed on publication year, country, and study type. As per the MASCC Guidelines Policy, the findings were synthesized to determine the levels of evidence to support each MBO intervention a …
The review was restricted to studies published in English, but no restrictions were placed on publication year, country, and study type. As …
The Antiobesity Effect and Safety of GLP-1 Receptor Agonist in Overweight/Obese Patients Without Diabetes: A Systematic Review and Meta-Analysis.
Guo X, Zhou Z, Lyu X, Xu H, Zhu H, Pan H, Wang L, Yang H, Gong F. Guo X, et al. Horm Metab Res. 2022 Jul;54(7):458-471. doi: 10.1055/a-1844-1176. Epub 2022 May 5. Horm Metab Res. 2022. PMID: 35512849 Free article.
However, GLP-1RAs treatments had more gastrointestinal adverse events (such as nausea and vomiting) than placebo and Met. The subgroup analysis also represented that semaglutide displayed the lowest risk of gastrointestinal adverse events among three kinds of GLP-1R …
However, GLP-1RAs treatments had more gastrointestinal adverse events (such as nausea and vomiting) than placebo and Met. The …
Efficacy and safety of oral semaglutide in type 2 diabetes mellitus: A systematic review and meta-analysis.
Li A, Su X, Hu S, Wang Y. Li A, et al. Diabetes Res Clin Pract. 2023 Apr;198:110605. doi: 10.1016/j.diabres.2023.110605. Epub 2023 Mar 5. Diabetes Res Clin Pract. 2023. PMID: 36871874 Review.
Semaglutide 14 mg did increase the incidence of medication discontinuation and gastrointestinal events (nausea, vomiting and diarrhea). CONCLUSION: Once-daily semaglutide 7 and 14 mg can significantly lowered HbA1c and body weight in patients with T2DM, and this eff …
Semaglutide 14 mg did increase the incidence of medication discontinuation and gastrointestinal events (nausea, vomiting and d …
Weight loss efficiency and safety of tirzepatide: A Systematic review.
Lin F, Yu B, Ling B, Lv G, Shang H, Zhao X, Jie X, Chen J, Li Y. Lin F, et al. PLoS One. 2023 May 4;18(5):e0285197. doi: 10.1371/journal.pone.0285197. eCollection 2023. PLoS One. 2023. PMID: 37141329 Free PMC article.
Additionally, the gastrointestinal adverse events (including diarrhea, nausea, vomiting and decreased appetite) of tirzepatide were higher than those of placebo/basal insulin, but similar to GLP-1 RAs. ...
Additionally, the gastrointestinal adverse events (including diarrhea, nausea, vomiting and decreased appetite) of tirzepatide …
Music interventions for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis.
Wei TT, Tian X, Zhang FY, Qiang WM, Bai AL. Wei TT, et al. Support Care Cancer. 2020 Sep;28(9):4031-4041. doi: 10.1007/s00520-020-05409-w. Epub 2020 Apr 23. Support Care Cancer. 2020. PMID: 32328772
BACKGROUND: Chemotherapy-induced nausea and vomiting (CINV) is the most common and severe side effects brought by chemotherapeutics. ...Results showed that music interventions were associated with reducing the incidence of anticipatory CINV and lowering the severity …
BACKGROUND: Chemotherapy-induced nausea and vomiting (CINV) is the most common and severe side effects brought by chemotherape …
Dexamethasone or combined with others for postoperative nausea and vomiting in children: A systematic review.
Liu J, Li H, Zhang J, Dong X, Xue J, Shi X, Yang K. Liu J, et al. Asian J Surg. 2020 Sep;43(9):873-879. doi: 10.1016/j.asjsur.2019.11.012. Epub 2020 Jan 18. Asian J Surg. 2020. PMID: 31964583 Free article.
Postoperative nausea and vomiting (PONV) is one of the most common and unpleasant postoperative complications in children. ...
Postoperative nausea and vomiting (PONV) is one of the most common and unpleasant postoperative complications in children. ...
Pinellia ternata-containing traditional Chinese medicine combined with 5-HT3RAs for chemotherapy-induced nausea and vomiting: A PRISMA-compliant systematic review and meta-analysis of 22 RCTs.
Zhai X, He Q, Chen M, Yu L, Tong C, Chen Y, Wang J, Fan X, Xie H, Liang Z, Sui X, Zeng L, Wu Q. Zhai X, et al. Phytomedicine. 2023 Jul;115:154823. doi: 10.1016/j.phymed.2023.154823. Epub 2023 Apr 14. Phytomedicine. 2023. PMID: 37099981
BACKGROUND: Pinellia ternata (P. ternata, Banxia)-containing traditional Chinese medicine (TCM) is widely used in China as an adjuvant treatment for chemotherapy-induced nausea and vomiting (CINV). However, evidence of its efficacy and safety remains limited. ...How …
BACKGROUND: Pinellia ternata (P. ternata, Banxia)-containing traditional Chinese medicine (TCM) is widely used in China as an adjuvant treat …
Industrial odour pollution and human health: a systematic review and meta-analysis.
Guadalupe-Fernandez V, De Sario M, Vecchi S, Bauleo L, Michelozzi P, Davoli M, Ancona C. Guadalupe-Fernandez V, et al. Environ Health. 2021 Sep 22;20(1):108. doi: 10.1186/s12940-021-00774-3. Environ Health. 2021. PMID: 34551760 Free PMC article. Review.
We considered outcomes for which there was a biological plausibility, such as wheezing and asthma, cough, headache, nausea and vomiting (primary outcomes). We also included stress-related symptoms and novel outcomes (e.g. mood states). ...The overall odds rat …
We considered outcomes for which there was a biological plausibility, such as wheezing and asthma, cough, headache, nausea and vom …
Efficacy and Safety of Olanzapine for the Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Meena JP, Gupta AK, Jat KR, Anandani G, Sasidharan A, Tanwar P. Meena JP, et al. J Pediatr Hematol Oncol. 2023 Oct 1;45(7):361-369. doi: 10.1097/MPH.0000000000002737. Epub 2023 Aug 3. J Pediatr Hematol Oncol. 2023. PMID: 37539996
Chemotherapy-induced nausea and vomiting (CINV) remain the most distressing event in patients receiving highly emetogenic chemotherapy (HEC) and moderately emetogenic chemotherapy (MEC). ...The pooled analysis of this meta-analysis found that olanzapine had a higher …
Chemotherapy-induced nausea and vomiting (CINV) remain the most distressing event in patients receiving highly emetogenic chem …
110 results